Science

Gene test can show drug-induced injury to liver: Study

Prashasti Awasthi Mumbai | Updated on September 08, 2020 Published on September 08, 2020

‘Our genetic score will potentially benefit people directly as a consumer diagnostic-like app. It could (also) show their risk of developing drug-induced liver injury’

According to a new study published in the journal Nature Medicine, any drug, approved or experimental, can pose a threat to the liver.

The study was carried out by a consortium of scientists from Cincinnati Children’s, Tokyo Medical and Dental University, Takeda Pharmaceutical Co in Japan, and several other research centres in Japan, Europe, and the US.

A corresponding author, Takanori Takebe, MD, an organoid expert at Cincinnati Children’s said in the study: “Our genetic score will potentially benefit people directly as a consumer diagnostic-like application, such as 23andMe and others. People could take the genetic test and know their risk of developing DILI (drug-induced liver injury).”

The research team developed the risk score by re-analysing hundreds of genome-wide association studies (GWAS).

The team found a long list of gene variants that could reveal the likelihood of a poor reaction in the liver to various compounds of the drug.

The researchers believe that this will help doctors and medical health practitioners change doses or formulate a new prescription entirely according to how patients’ livers react to the drug.

Researchers maintained that the gene tests could help exclude people at high risk of liver injury from a clinical trial or high dose of medication as their liver reactions can be more accurately assessed.

Takebe added that more research is needed that could involve a diverse population to confirm the initial findings and to scale up a DILI screening test for potentially widespread use.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on September 08, 2020
This article is closed for comments.
Please Email the Editor